What is SVA stock price today?

Visit our real-time dashboard for the current SVA stock price and live market data.

Is SVA stock going up or down today?

SVA stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy SVA stock now?

The decision to buy SVA depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is SVA a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for SVA based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is SVA stock overvalued or undervalued?

SVA currently trades at a P/E ratio of 6.66, which may suggest attractive valuation. Our DCF calculator provides intrinsic value estimates to help determine if SVA is fairly priced.

What is SVA's P/E ratio?

SVA has a price-to-earnings (P/E) ratio of 6.66, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.

What is SVA's market cap?

SVA (Sinovac Biotech Ltd) has a market capitalization of $0.64 billion, making it a small-cap stock.

What is SVA's price to book ratio?

Price-to-book ratio for SVA is available on our dashboard along with other valuation metrics.

Does SVA pay dividends?

Yes, SVA pays dividends with a current yield of 850.08%. Dividend payments provide income for investors in addition to potential stock price appreciation.

What is SVA's dividend yield?

SVA's dividend yield is 850.08%, calculated as annual dividends divided by the current stock price. This represents the annual return from dividends alone.

Is SVA stock a good long-term investment?

SVA's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is SVA's revenue growth rate?

Revenue growth data for SVA is available on our dashboard with detailed financial statement analysis.

Profitability metrics for SVA are available on our dashboard with complete income statement analysis.

What are the risks of investing in SVA?

Key risks for SVA include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does SVA compare to its competitors?

Compare SVA to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize SVA's performance and positioning.

What is SVA's stock price target for 2026?

Visit our prediction page for AI-powered price targets for SVA with bull, base, and bear case scenarios.

What do analysts say about SVA?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for SVA. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is SVA's next earnings report?

SVA reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

SVA - Sinovac Biotech Ltd

NYSE * Healthcare * Biotechnology

$0.00

+$0.00 (+0.00%)

About Sinovac Biotech Ltd

Sinovac Biotech Ltd (SVA) common stock

Price Chart

Loading chart...

SVA Key Statistics

Market Cap

$642.44M

P/E Ratio

6.66

Dividend Yield

850.08%

How SVA Compares to Peers

SVA has the lowest P/E ratio in Biotechnology, suggesting it may be the most undervalued

SVA is the smallest among peers, which may offer higher growth potential

P/E Rank

of 6

Margin Rank

N/A

of 0

Growth Rank

N/A

of 0

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
SVA(This stock)	$642.44M	6.7	0%	0.0%	-
AMGNAmgen Inc	$188.67B	24.3	0%	0.0%	vs AMGN
GILDGilead Sciences	$160.15B	17.5	0%	0.0%	vs GILD
VRTXVertex Pharmaceuticals	$106.87B	29.7	0%	0.0%	vs VRTX
REGNRegeneron Pharmaceuticals	$59.10B	13.9	0%	0.0%	vs REGN
BIIBBiogen Inc	$29.33B	21.4	0%	0.0%	vs BIIB

Data Updated: July 16, 2026 at 5:55 PM EDT

Ready to invest in SVA?

Commission-free trading available. Affiliate links.

Upcoming Events for SVA

Dashboard

Enter a ticker to analyze